2026 newest
PHARMACOLOGY
INTRODUCTION
Pharmacology is the study of drugs and their interactions with living
systems. For FNPs, a deep understanding of pharmacology is crucial
as it forms the basis for prescribing medications, understanding
drug interactions, and managing patient care. This section covers
the core principles of pharmacology, emphasizing their application
in clinical practice.
DRUG CLASSIFICATIONS AND
MECHANISMS OF ACTION
1. ANTIHYPERTENSIVES
Beta-Blockers: Beta-blockers, such as metoprolol and atenolol, work by blocking beta-
adrenergic receptors in the heart, reducing heart rate and myocardial contractility. They are
commonly used in the management of hypertension, angina, and heart failure. FNPs must be
aware of contraindications, such as in patients with asthma or chronic obstructive pulmonary
disease (COPD), where beta-blockers may exacerbate symptoms.
ACE Inhibitors and ARBs: Angiotensin-Converting Enzyme (ACE) inhibitors like lisinopril and
Angiotensin II Receptor Blockers (ARBs) like losartan reduce blood pressure by inhibiting the
renin-angiotensin-aldosterone system. They are particularly beneficial in patients with diabetes
or chronic kidney disease due to their renal-protective effects.
Calcium Channel Blockers: Drugs such as amlodipine and diltiazem inhibit calcium influx into
smooth muscle cells, causing vasodilation and decreased peripheral resistance. They are useful
in treating hypertension and certain types of arrhythmias. FNPs should monitor for potential
side effects like peripheral edema and bradycardia.
Aa
, Diuretics: Diuretics, including thiazides (hydrochlorothiazide),
loop diuretics (furosemide), and potassium-sparing diuretics
(spironolactone), promote diuresis and are commonly used in
hypertension and heart failure management. Understanding
the electrolyte disturbances associated with diuretics, such as
hypokalemia or hyperkalemia, is crucial for safe prescribing.
Aa
, PHARMACOLOGY
DRUG CLASSIFICATIONS AND
MECHANISMS OF ACTION
2. ANTIBIOTICS
Penicillins: Penicillin and its derivatives (e.g., amoxicillin)
inhibit bacterial cell wall synthesis, making them effective
against a wide range of gram-positive organisms.
They are often the first-line treatment for infections
such as streptococcal pharyngitis and otitis media.
FNPs must assess for potential allergies and be
prepared to offer alternatives, such as cephalosporins
or macrolides.
Cephalosporins: This class, divided into generations,
has a broad spectrum of activity. First-generation
cephalosporins (e.g., cefazolin) are effective against
gram-positive bacteria, while later generations (e.g., ceftriaxone) cover more gram-negative
organisms. They are used for a variety of infections, including respiratory and urinary tract
infections.
Macrolides: Macrolides, like azithromycin and clarithromycin, inhibit bacterial protein synthesis.
They are particularly useful in patients allergic to penicillin and in treating atypical infections like
Mycoplasma pneumoniae. Monitoring for drug interactions, especially with statins and warfarin, is
important due to macrolides' potential to inhibit cytochrome P450 enzymes.
Fluoroquinolones: Ciprofloxacin and levofloxacin are broad-spectrum antibiotics effective
against gram-negative and some gram-positive bacteria. They are commonly used for complicated
urinary tract infections, respiratory infections, and gastrointestinal infections. FNPs should be
cautious of potential side effects, including tendonitis and QT prolongation.
Antibiotic Stewardship: Understanding and implementing principles of antibiotic stewardship is
essential to prevent the development of antibiotic resistance. This includes prescribing antibiotics
only when necessary, choosing the appropriate antibiotic, and educating patients on the
importance of completing prescribed courses.